NewsResearch
What Is Immunotherapy? Understanding a Term You See in Cancer News
Immunotherapy is one of the most talked-about cancer treatments. Here's what it actually is, the main types, and what NCI says about how it works.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
One word covering five different things
Headlines use "immunotherapy" as though it named a drug. It does not. It names a strategy. The treatments inside it work in ways that have little in common.
NCI puts it simply. Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. It sits inside a wider family called biological therapy. That means treatment made from substances produced by living things.
Knowing the categories is what makes cancer news readable. A story about one of them tells you nothing about the others.
Why the immune system needs help
The immune system already does this job. NCI notes that it detects and destroys abnormal cells as part of its normal work. It most likely prevents or slows the growth of many cancers.
You can see it happening. Immune cells are often found in and around tumors. They are called tumor-infiltrating lymphocytes, or TILs. NCI reports that people whose tumors hold TILs often do better than people whose tumors do not.
But any cancer a doctor can see has already got past that defense. NCI describes three ways they manage it. Gene changes make the cancer cells harder to spot. Proteins on their surface switch immune cells off. And they alter the normal tissue around the tumor so the immune system responds poorly.
Each escape route calls for a different answer. That is why there are several kinds of this treatment rather than one.
The five types NCI lists
Immune checkpoint inhibitors. Checkpoints are a normal brake on the immune system. They stop responses running out of control. Some cancers use them to switch off the immune cells that arrive. These drugs block the brake. Immune cells can then respond more strongly.
T-cell transfer therapy. Immune cells are taken from a person's tumor. The ones most active against that cancer are picked out. Some are altered in a lab to attack it better. They are grown in large numbers, then returned through a vein. NCI also calls this adoptive cell therapy.
Monoclonal antibodies. Immune proteins made in a lab. Each is built to stick to one target on cancer cells. NCI notes that some work by marking those cells so the immune system finds and destroys them. Those are the ones counted here.
Treatment vaccines. These go to someone who already has cancer. They strengthen the immune response against it. NCI keeps them separate from vaccines that prevent disease.
Immune system modulators. These boost the immune response. Some target one part of it. Others act more broadly.
Our overview of immunotherapy covers each in more depth. Targeted therapy covers the other family it gets confused with.
How it is actually given
NCI lists four routes. They are not swaps for each other. Into a vein. By mouth, as pills or capsules. As a cream rubbed on the skin, used for some very early skin cancers. Or straight into the bladder.
Most of it happens in a doctor's office, a clinic, or a hospital day unit. You do not stay overnight.
Where it fits, and where it does not
NCI is measured about scale. These drugs are approved for many types of cancer. But the approach is not yet as widely used as surgery, chemotherapy or radiation.
For some cancers it is now central. Take non-small cell lung cancer. NCI's clinical summary describes testing tumors for a protein called PD-L1, alongside gene changes. Those results help decide whether checkpoint inhibitors are used, and how.
For other cancers it has little or no role yet. Whether it is an option depends on the specific cancer, its molecular features, and the person's situation — which is why "immunotherapy" appearing in the news is not itself information about anyone's treatment. Our cancer treatment overview puts the options side by side.
When to call the team
Immunotherapy side effects are different in kind from chemotherapy's, and this is the practical thing to know about them. NCI explains the mechanism: many happen when an immune system revved up against the cancer also acts against healthy cells and tissues.
So a reaction can appear in almost any organ. It often starts weeks or months into treatment. It can start after treatment ends. Report these to your team the same day:
- Diarrhea that is new, or more than a couple of extra stools a day, or any blood or mucus.
- A new cough, breathlessness, or chest pain.
- A rash that is spreading, blistering, or intensely itchy.
- Yellowing of the skin or eyes, or dark urine.
- Odd tiredness, feeling cold all the time, dizziness on standing, or a racing heart. These can signal a hormone gland being hit.
- New or worsening headaches, visual changes, muscle weakness, or numbness.
The urgency has a reason. These reactions are treatable, usually with steroids. They respond better when caught early. Anyone on these drugs should be able to reach an on-call service at any hour. Name the drug to any clinician who sees you, including in an emergency department.
What this does not mean
- This is not a single treatment. A result in one cancer, with one drug class, says nothing about another.
- It is not chemotherapy's gentler replacement. It has its own serious risks, and they can be permanent.
- It is not available or suitable for everyone. Approval goes by cancer type, by situation, and often by a biomarker result.
- And a news story about a trial is not a statement about anyone's care. Whether any of this applies to a specific person is a clinical question with a clinical answer.
Sources
- NCI: Immunotherapy for Cancer
- NCI PDQ: Non-Small Cell Lung Cancer Treatment (Health Professional Version)
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Immunotherapy. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.